CPAP decreases lung hyperinflation in patients with stable COPD
Agnaldo J Lopes1, Flávio Pos Nery, Felipe C Sousa
1Rehabilitation Science Graduate Program, Augusto Motta University, Rio de Janeiro, Brazil.
Respiratory Care
|April 19, 2011
Summary
Continuous positive airway pressure (CPAP) can reduce lung volumes and airway resistance in patients with COPD. However, these benefits for dynamic hyperinflation are temporary, lasting only 15 minutes.
Area of Science:
- Respiratory Medicine
- Pulmonary Physiology
Background:
- Dynamic hyperinflation significantly increases resting lung volumes in COPD patients due to expiratory flow limitation.
- Resting end-expiratory lung volume, or functional residual capacity, is markedly elevated in many individuals with COPD.
Purpose of the Study:
- To investigate the immediate and sustained effects of continuous positive airway pressure (CPAP) on hyperinflation.
- To assess the impact of CPAP on airway resistance in stable COPD patients.
Main Methods:
- A case series involving 21 patients with stable COPD was conducted.
- Patients received CPAP at 8 cm H2O for 15 minutes.
- Whole-body plethysmography was used to measure lung volumes and airway resistance immediately after CPAP and at 15 and 30 minutes post-treatment.
Main Results:
- CPAP treatment led to significant reductions in residual volume, functional residual capacity, total lung capacity, RV/TLC ratio, and airway resistance.
- These beneficial effects persisted for 15 minutes post-CPAP.
- However, lung volumes returned to baseline levels by 30 minutes after CPAP cessation.
Conclusions:
- Continuous positive airway pressure (CPAP) effectively reduces lung volumes and airway resistance in patients with severe to very severe stable COPD.
- The positive impact of CPAP on lung volumes and airway resistance is transient, lasting approximately 15 minutes.
- Lung volumes revert to pre-treatment baseline levels within 30 minutes after CPAP is discontinued.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...